Towa Pharmaceutical (OTCMKTS:TWAPF – Get Free Report) is anticipated to announce its resultson Thursday, May 14th. Analysts expect the company to announce earnings of $0.6790 per share and revenue of $468.8690 million for the quarter.
Towa Pharmaceutical Stock Performance
OTCMKTS TWAPF opened at $25.33 on Tuesday. Towa Pharmaceutical has a 1 year low of $16.83 and a 1 year high of $25.33. The firm’s 50 day simple moving average is $25.33 and its 200 day simple moving average is $25.33.
About Towa Pharmaceutical
Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.
In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.
See Also
- Five stocks we like better than Towa Pharmaceutical
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Towa Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Towa Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
